Sponsor or institution
Clinical trials and research at Jiangsu Nutai Biologics Co., Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Jiangsu Nutai Biologics Co., Ltd that are recruiting, in China. By phase: Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
SXRN injection for cancer-related anorexia-cachexia
This trial will see if SXRN injection is safe and can improve appetite, weight, or inflammation in adults with advanced solid tumors who have cancer-associated anorexia-cachexia.
-
SXRN Plasmid DNA Technique in Advanced Solid Tumors
This early-phase study tests the safety and tolerability of SXRN plasmid DNA given at different doses in adults with advanced solid tumors who have exhausted standard therapies.
Quick answers
How many clinical trials run by Jiangsu Nutai Biologics Co., Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.